FADS2, a member of the fatty acid desaturase family, is a key enzyme in the synthesis of polyunsaturated fatty acids (PUFAs), playing a vital role in tumour progression and chemotherapy resistance [21, 22]. The gene discussed is FADS2; the disease is neoplasm.